Award Synopsis MRI.pdf
PDF 91 KB Posted
- Solicitation number
- 75N93019R00023
About this file
This document provides details of an award synopsis and related federal contract opportunity for preclinical and translational vaccine development services. MRIGlobal was awarded a blanket purchase agreement with a maximum amount of $364,553,934 for the period of December 1, 2021 through November 30, 2028. The award is for PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR HIV AND OTHER CANDIDATE AGENTS in response to solicitation number 75N93019R00023 from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases. The services will be performed by MRIGlobal located in Kansas City, Missouri. The primary point of contact for the award is Kishan Patel, Contracting Officer, at the National Institute of Allergy and Infectious Diseases.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
AWARD SYNOPSIS
Type: Award
Date of Award: December 1, 2021
Period of Performance (including all options): December 1, 2021 through November 30, 2028
Title: "PRECLINICAL AND TRANSLATIONAL VACCINE DEVELOPMENT FOR
HIV AND OTHER CANDIDATE AGENTS”
(RFP) No.: 75N93019R00023
NAICS: 541715, Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Contract Number: 75N93022D00002
Total Estimated Cost (Including all Options): $364,553,934 maximum amount (IDIQ)
Place of Performance/Awardee:
MRIGlobal 425 Volker Boulevard Kansas City, MO 64110
DUNS: 007173453
Primary Point of Contact at NIAID: Kishan Patel Contracting Officer patelki@niaid.nih.gov mailto:patelki@niaid.nih.gov
File details come from the government source that posted it. Updated .